Superoxide Dismutase (SOD) Activity Assay Kit: Practical Use
2026-05-02
The Superoxide Dismutase (SOD) Activity Assay Kit (SKU K2035) enables quantitative measurement of SOD activity in biological fluids, supporting rigorous oxidative stress research where accuracy and reproducibility are critical. It is best used for colorimetric detection of antioxidative enzyme function, but should not be applied to diagnostic or medical workflows. The kit is unsuitable for settings requiring direct clinical interpretation or mechanistic claims beyond its validated colorimetric range.
In Vitro Pharmacodynamics of Gamithromycin Against MmmSC
2026-05-02
This study provides the first detailed in vitro pharmacodynamic analysis of Gamithromycin, ML-1709460, against Mycoplasma mycoides subspecies mycoides Small Colony—the causative agent of contagious bovine pleuropneumonia. The findings clarify serum potentiation effects, comparative efficacy with older macrolides, and inform future research design for bovine respiratory disease therapeutics.
Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S
2026-05-01
This study introduces a novel assembloid model integrating patient-matched gastric tumor organoids and stromal cell subpopulations, offering an advanced platform to capture tumor heterogeneity and microenvironmental influences on drug response. The approach enhances preclinical research by enabling detailed investigation of resistance mechanisms and supporting personalization of gastric cancer therapies.
Starvation Triggers Autophagy–Apoptosis Switch via ER-Ca2+-C
2026-04-30
This study elucidates how starvation in Bombyx mori induces a precise transition from autophagy to apoptosis in the fat body through the ER-Ca2+-calpain pathway. The work reveals IP3R-mediated calcium signaling as a key regulatory axis and demonstrates that pharmacological inhibition of this pathway modulates cell fate under nutritional stress.
Gamithromycin: Precision Use in Veterinary Respiratory Disea
2026-04-30
Gamithromycin (ML-1709460) empowers translational and veterinary scientists with optimized, evidence-backed protocols for tackling respiratory pathogens like Haemophilus parasuis and Pasteurella multocida. APExBIO’s formulation delivers reproducibility and data-driven performance in both in vitro and in vivo models.
ALOX5 Deficiency Drives Ferroptosis Escape in Bladder Cancer
2026-04-29
This study identifies ALOX5 deficiency as a key mechanism for ferroptosis resistance in advanced bladder cancer, linking low ALOX5 expression to poor prognosis. By elucidating the transcriptional regulation of ALOX5 and its impact on lipid peroxidation, the research provides a foundation for novel therapeutic strategies targeting ferroptosis pathways.
Targeted mRNA Nanoparticles Restore BBB After Ischemic Strok
2026-04-29
Gao et al. (2024) developed targeted lipid nanoparticles delivering IL-10 mRNA to modulate microglia in ischemic stroke, restoring the blood-brain barrier and reducing neuroinflammation. This approach demonstrates a promising mRNA-based platform for precise therapeutic intervention in acute brain injury.
AQP9 Downregulation in KRASG12V Colorectal Cancer: Mechanist
2026-04-28
This study identifies a pronounced downregulation of Aquaporin 9 (AQP9) in colorectal cancer (CRC) cases harboring the KRASG12V mutation, correlating with increased tumor proliferation and reduced apoptosis. The research uncovers a mechanistic link mediated by ZHX2, suggesting a potential therapeutic avenue for targeting aggressive KRASG12V CRC subtypes.
Saquinavir in Advanced Permeability Modeling: A New Era for
2026-04-28
Explore how Saquinavir, a leading HIV protease inhibitor, enables advanced permeability modeling and predictive pharmacokinetics in cutting-edge antiretroviral drug research. This article uniquely bridges molecular assay design and high-throughput membrane interaction analysis.
Biochemical Profiling of GOB-38 β-Lactamase in E. anophelis
2026-04-27
This study characterizes the GOB-38 metallo-β-lactamase (MBL) variant from Elizabethkingia anophelis, revealing its broad substrate specificity and structural features that may enhance carbapenem resistance. The findings provide crucial insights into resistance transmission in clinical co-infections and inform the design of β-lactamase assays for emerging pathogens.
PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Applied
2026-04-27
PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, empowers researchers to dissect the ubiquitin-proteasome system and modulate NF-κB signaling with precision. This guide translates bench-proven protocols and troubleshooting strategies into actionable insights for protein degradation and inflammation models.
Ibrexafungerp and Caspofungin Against Resistant Candida auri
2026-04-26
Wiederhold et al. systematically benchmarked ibrexafungerp and caspofungin for activity against fluconazole-resistant Candida auris, including with delayed therapy initiation. Their study reveals both agents' efficacy in reducing fungal burden and improving survival, highlighting the importance of β-(1,3)-D-glucan biosynthesis inhibition for managing multidrug-resistant Candida infections.
Dual Glutamate Receptor Blockade Mitigates Soman-Induced Neu
2026-04-25
This study demonstrates that IEM-1925, a dual AMPA/NMDA receptor antagonist, provides superior seizure suppression, neuroprotection, and cognitive improvement compared to standard therapy in a rat model of soman-induced status epilepticus. The findings underscore the translational value of targeted glutamate receptor inhibition for organophosphorus nerve agent (OPNA) exposure.
Disentangling Proliferative Arrest and Cell Death in Cancer
2026-04-24
Schwartz's dissertation introduces a refined approach to evaluating anti-cancer drug responses in vitro by distinguishing between proliferative arrest and cell death. This methodological advance enables more precise interpretation of drug effects, enhancing assay design and data analysis in cancer research.
Thiamet G: Precision O-GlcNAcase Inhibition in Ferroptosis a
2026-04-24
Explore how Thiamet G, a selective O-GlcNAcase inhibitor, enables advanced research into O-GlcNAcylation, ferroptosis, and trophoblast biology. This article uniquely bridges neurodegenerative, cancer, and reproductive disease models, offering insights beyond standard applications.
457 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page